Award
NIH Reporter #5U01AI155361-05
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
Recipient
Not Specified
Award Amount
$882,985.00
Ceiling
$882,985.00
Awarded
December 20, 2024
Identifier
5U01AI155361-05
Award for developing a multivalent vaccine against Plasmodium vivax, funded by NIAID, focusing on vaccine development and infectious disease research to combat vivax malaria.
Description
The project aims to develop a multivalent vaccine to prevent Plasmodium vivax infection. The project is funded by the National Institute of Allergy and Infectious Diseases (NIAID) and involves vaccine development, immunology, and infectious disease research as part of a broader effort to combat malaria, especially vivax malaria.